Cargando…

Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial

BACKGROUND: Magnesium sulfate is the ideal drug for the prevention and treatment of eclampsia. Nevertheless, the best regimen for protection against eclampsia with minimal side effects remains to be established. This study aimed to compare serum magnesium levels during intravenous infusion of magnes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pascoal, Ana C. F., Katz, Leila, Pinto, Marcela H., Santos, Carina A., Braga, Luana C. O., Maia, Sabina B., Amorim, Melania M. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709127/ https://www.ncbi.nlm.nih.gov/pubmed/31393402 http://dx.doi.org/10.1097/MD.0000000000016779

Ejemplares similares

Clinical outcomes in neonates following maternal magnesium sulfate therapy in preeclampsia/eclampsia
por: Tikhova, G, et al.
Publicado: (2012)

Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia
por: Padda, Jaskamal, et al.
Publicado: (2021)

Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial
por: Vigil-De Gracia, Paulino, et al.
Publicado: (2017)

Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors
por: da Costa, Tatiana Xavier, et al.
Publicado: (2020)

Obstetrician’s risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil
por: Lotufo, Fátima Aparecida, et al.
Publicado: (2017)

The Unusual Suspect: Hypocalcemia in Preeclampsia After Magnesium Infusion
por: Abdulhadi, Basma, et al.
Publicado: (2021)

Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil
por: Lotufo, Fátima Aparecida, et al.
Publicado: (2016)

An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia
por: Brookfield, Kathleen, et al.
Publicado: (2021)

Treatment of Eclampsia with Magnesium Sulphate
por: Quddus, M. A.
Publicado: (1946)

Iatrogenic Hypermagnesemia in a Patient With Preeclampsia Caused by Misinterpretation of the Magnesium Reporting Unit Following Magnesium Sulfate Administration
por: Omer, Mohamed S, et al.
Publicado: (2022)

Recurrent Seizures in 2 Patients with Magnesium Sulfate-Treated Eclampsia at a Secondary Hospital
por: Harsono, Alfonsus Adrian Hadikusumo, et al.
Publicado: (2018)

Evaluation of intravenous infusion of labetalol versus magnesium sulfate on cerebral hemodynamics of preeclampsia patients with severe features using transcranial doppler
por: Mowafy, Sherif M. S., et al.
Publicado: (2023)

Correlation of 2 Hour, 4 Hour, 8 Hour and 12 Hour Urine Protein with 24 Hour Urinary Protein in Preeclampsia
por: Rani Singhal, Savita, et al.
Publicado: (2014)

It Takes a System: Magnesium Sulfate for Prevention of Eclampsia in a Resource-Limited Community Setting
por: Goldenberg, Robert L., et al.
Publicado: (2019)

Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice
por: Bigdeli, Maryam, et al.
Publicado: (2013)

Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015)

Comparison of Preoperative Infusion of Magnesium Sulfate and Mannitol on Intraocular Pressure Changes in Patients Undergoing Phacoemulsification Surgery
por: Montazeri, Kamran, et al.
Publicado: (2018)

Intravenous infusion of magnesium sulfate and its effect on horses with trigeminal‐mediated headshaking
por: Sheldon, Shara A., et al.
Publicado: (2019)

Continuous Magnesium Sulfate Infusions for Status Asthmaticus in Children: A Systematic Review
por: Johnson, Peter N., et al.
Publicado: (2022)

Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus
por: Taher, Khalid W., et al.
Publicado: (2022)

Analysis on Clinical Outcomes of Low-Molecular Weight Heparin Combined with Magnesium Sulfate in Patients with Pre-Eclampsia
por: Wang, Ningning, et al.
Publicado: (2022)

Use Profile of Magnesium Sulfate in Anesthesia in Brazil
por: Cavalcanti, Ismar Lima, et al.
Publicado: (2019)

Eclampsia Treated with Intravenous Injection of Magnesium Sulphate Solution
por: Roy, S. K.
Publicado: (1941)

Magnesium sulfate and ophthalmic artery Doppler velocimetry in patients with severe preeclampsia: a case series
por: Oliveira, Cristiane Alves, et al.
Publicado: (2017)

Risk factors for sub–therapeutic serum concentrations of magnesium sulfate in severe preeclampsia of Chinese patients
por: Li, Jingjing, et al.
Publicado: (2020)

Effect of continuous magnesium sulfate infusion on spinal block characteristics: A prospective study
por: Agrawal, Akansha, et al.
Publicado: (2014)

Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults
por: Karhu, Elisa, et al.
Publicado: (2018)

The comparison of anti-seizure and tocolytic effects of phenytoin and magnesium sulphate in the treatment of eclampsia and preeclampsia: A randomised clinical trial
por: Khooshideh, Maryam, et al.
Publicado: (2017)

Analgesic effect of adding magnesium sulfate to epidural levobupivacaine in patients with pre-eclampsia undergoing elective cesarean section
por: Elsharkawy, Reem Abdelraouf, et al.
Publicado: (2018)

Magnesium Toxicity-Induced Ileus in a Postpartum Patient Treated for Preeclampsia With Magnesium Sulphate
por: Al-Shoha, Mohammad, et al.
Publicado: (2015)

Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid
por: Ware, Erin B., et al.
Publicado: (2019)

Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen
por: Ekele, Bissallah A, et al.
Publicado: (2009)

Effect of Magnesium Sulfate on Doppler Parameters of Fetal Umbilical and Middle Cerebral Arteries in Women with Severe Preeclampsia
por: Farshchian, Nazanin, et al.
Publicado: (2012)

Magnesium Sulfate Treatment Reverses Seizure Susceptibility and Decreases Neuroinflammation in a Rat Model of Severe Preeclampsia
por: Johnson, Abbie Chapman, et al.
Publicado: (2014)

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia
por: Du, Lihong, et al.
Publicado: (2018)

Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension
por: Moriuchi, Kaori, et al.
Publicado: (2022)

A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion
por: Easterling, Thomas, et al.
Publicado: (2018)

Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia
por: Kassie, Gizat M., et al.
Publicado: (2014)

Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5pko7ohah11e57hor1gp2dchse